An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody

BMC Biotechnology

Volumn 9, Issue , 2009, Pages

  Kabir, M Enamul ^a   Krishnaswamy, Senthilkumar ^a   Miyamoto, Masahiko ^a   Furuichi, Yasuhiro ^b   Komiyama, Tadazumi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b GeneCare Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SITE; ANTI-IDIOTYPIC ANTIBODIES; BINDING AFFINITIES; BINDING PROPERTIES; BIOMEDICAL RESEARCH; CANDIDA SPECIES; CDNA LIBRARIES; COMPETITIVE BINDING; ELUTION CONDITIONS; FUNCTIONAL SIMILARITY; INTEGRAL PART; SACCHAROMYCES; SIMPLE MODIFICATIONS; SINGLE CHAINS; SOLID SUPPORTS; SPR ANALYSIS;

ANTIGENS; BACTERIOPHAGES; BINDING ENERGY; MONOCLONAL ANTIBODIES;

SURFACE PLASMON RESONANCE;

ANTIIDIOTYPIC ANTIBODY; BUFFER; COMPLEMENTARY DNA; HM 1 KILLER TOXIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; FUNGUS ANTIBODY; IMMOBILIZED ANTIBODY; PEPTIDE LIBRARY; RECOMBINANT PROTEIN; SINGLE CHAIN ANTIBODIES; YEAST KILLER FACTOR;

ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; BIOPANNING; CANDIDA; CONTROLLED STUDY; DISSOCIATION; DNA LIBRARY; ELUTION; GENOTYPE; IMMOBILIZATION; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY; SACCHAROMYCES; SURFACE PLASMON RESONANCE; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; BIOSYNTHESIS; CHEMISTRY; DNA FINGERPRINTING; DNA SEQUENCE; ENZYME ACTIVE SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; WILLIOPSIS;

CANDIDA; SACCHAROMYCES;

AMINO ACID SEQUENCE; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, FUNGAL; ANTIBODIES, IMMOBILIZED; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIFUNGAL AGENTS; CATALYTIC DOMAIN; CLONING, MOLECULAR; DNA FINGERPRINTING; ENZYME-LINKED IMMUNOSORBENT ASSAY; KILLER FACTORS, YEAST; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SINGLE-CHAIN ANTIBODIES; WILLIOPSIS;

EID: 74049140009     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-9-99     Document Type: Article

References (44)

1. Myskowski PL, White MH, Ahkami R. Fungal disease in the immunocompromised host. Dermatol Clin 1997, 15:295-305. 10.1016/S0733-8635(05)70437-X, 9098638.
2. Kordossis T, Avlami A, Velegraki A, Stefanou I, Georgakopoulos G, Papalambrou C, Legakis NJ. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med Mycol 1998, 36:335-339.
3. Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T. Inhibition of Fungal β-1,3-Glucan Synthase and Cell Growth by HM-1 Killer Toxin Single-Chain Anti-Idiotypic Antibodies. Antimicrob Agents Chemother 2006, 50:3090-3097. 10.1128/AAC.01435-05, 1563539, 16940106.
4. Travassos LR, Silva LS, Rodrigues EG, Conti S, Salati A, Magliani W, Polonelli L. Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis. J Antimicrob Chemother 2004, 54:956-958. 10.1093/jac/dkh430, 15448128.
5. Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. Nature 1991, 352:624-628. 10.1038/352624a0, 1907718.
6. Gram H, Marconi LA, Barbas CF, Collet TA, Lerner RA, Kang AS. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci USA 1992, 89:3576-3580. 10.1073/pnas.89.8.3576, 48911, 1565653.
7. Griffiths AD, Malmqvist M, Marks JD, Bye JM, Embleton MJ, McCafferty J, Baier M, Holliger KP, Gorick BD, Hughes-Jones NC, Hoogenboom HR, Winter G. Human anti-self antibodies with high specificity from phage display libraries. EMBO J 1993, 12:725-734. 413258, 7679990.
8. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228:1315-1317. 10.1126/science.4001944, 4001944.
9. Begent RH, Verhaar MJ, Chester KA, Casey GL, Green AJ, Napier MP, Hope-Stone LD, Cushen N, Keep PA, Johnson CJ, Hawkins RE, Hilson AJ, Robson L. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat Med 1996, 2:979-984. 10.1038/nm0996-979, 8782454.
10. Hoogenboom HR, Winter G. By-passing immunization: human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J Mol Biol 1992, 227:381-388. 10.1016/0022-2836(92)90894-P, 1404359.
11. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991, 222:581-597. 10.1016/0022-2836(91)90498-U, 1748994.
12. Yau KYF, Tout NL, Trevors JT, Lee H, Hall JC. Bacterial expression and characterization of a picloram-specific recombinant Fab for residue analysis. J Agric Food Chem 1998, 46:4457-4463.
13. Griffiths AD, Duncan AR. Strategies for selection of antibodies by phage display. Curr Opin Biotechnol 1998, 9:102-108. 10.1016/S0958-1669(98)80092-X, 9503596.
14. Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J, Bosshard HR, Pluckthun A. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods 1997, 201:35-55. 10.1016/S0022-1759(96)00208-6, 9032408.
15. Watters JM, Telleman P, Junghans RP. An optimized method for cell-based phage display panning. Immunotechnology 1997, 3:21-29. 10.1016/S1380-2933(96)00056-5, 9154465.
16. Bruin RD, Spelt K, Mol J, Koes R, Quattrocchio F. Selection of high-affinity phage antibodies from phage display libraries. Nat Biotechnol 1999, 17:397-399. 10.1038/7959, 10207892.
17. Kobayashi N, Tsuyoshi K, Junichi G. Dissociation-independent selection of high-affinity anti-hapten phage antibodies using cleavable biotin-conjugated haptens. Anal Biochem 2005, 347:287-96. 10.1016/j.ab.2005.09.016, 16288966.
18. Guo X, Chen RR. An improved phage display procedure for identification of lipopolysaccharide-binding peptides. Biotechnol Prog 2006, 22:601-604. 10.1021/bp050315o, 16599583.
19. Li N, Erman M, Pangborn W, Duax WL, Park CM, Bruenn J, Ghosh D. Structure of Ustilago maydis Killer Toxin KP6a-subunit: A Multimeric Assembly with a Central Pore. J Biol Chem 1999, 274:20425-20431. 10.1074/jbc.274.29.20425, 10400668.
20. Yamamoto T, Hiratani T, Hirata H, Imai M, Yamaguchi H. Killer toxin from Hansenula mrakii selectively inhibits cell wall synthesis in a sensitive yeast. FEBS Lett 1986, 197:50-54. 10.1016/0014-5793(86)80296-4, 3512308.
21. Antuch W, Guntert P, Wuthrich K. Ancestral beta gamma-crystallin precursor structure in a yeast killer toxin. Nat Struct Biol 1996, 3:662-66. 10.1038/nsb0896-662, 8756320.
22. Kasahara S, Yamada H, Mio T, Shiratori Y, Miyamoto C, Yabe T, Nakajima T, Ichishima E, Furuichi Y. Cloning of the Saccharomyces cerevisiae gene whose overexpression overcomes the effect of HM-1 killer toxin, which inhibits beta-glucan synthesis. J Bacteriol 1994, 5:1488-1499.
23. Takasuka T, Komiyama T, Furuichi Y, Watanabe T. Cell wall synthesis specific cytocidal effect of Hansenula mrakii toxin-1 on Saccharomyces cerevisiae. Cell Mol Biol Res 1995, 41:575-581.
24. Yamamoto T, Imai M, Tachibana K, Mayumi M. Application of monoclonal antibodies to the isolation and characterization of a killer toxin secreted by Hansenula mrakii. FEBS Lett 1986, 195:253-257. 10.1016/0014-5793(86)80170-3, 3943610.
25. Jhonson G, Wu TT. The Kabat database and a bioinformatics example. Methods Mol Biol 2004, 248:11-25.
26. Selvakumar D, Zhang QZ, Miyamoto M, Furuichi Y, Komiyama T. Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin. J Biochem 2006, 139:399-406. 10.1093/jb/mvj042, 16567405.
27. Nisonoff A, Gorish MF. From network theory toward vaccination by monoclonal antibodies. New horizons in microbiology 1984, 119-128. Elsevier Science Publishers, Amsterdam, The Netherlands, Sanna A, Morace G.
28. Monroe JG, Greene MI. Anti-idiotypic antibodies and disease. Immunol Investig 1986, 15:263-286.
29. Bruck C, Co MS, Slaoui M, Gaulton GN, Smith T, Fields BN, Mullins JI, Greene MI. Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci USA 1986, 83:6578-6582. 10.1073/pnas.83.17.6578, 386547, 2428036.
30. Gaulton GN, Greene MI. Idiotypic mimicry of biological receptors. Annu Rev Immunol 1986, 4:253-280. 10.1146/annurev.iy.04.040186.001345, 2423100.
31. Okamoto T, Mukai Y, Yoshioka Y, Shibata H, Kawamura M, Yamamoto Y, Nakagawa S, Kamada H, Hayakawa T, Mayumi T, Tsutsumi Y. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen. Biochem Biophys Res Commun 2004, 323:583-591. 10.1016/j.bbrc.2004.08.131, 15369791.
32. Selvakumar D, Karim N, Miyamoto M, Furuichi Y, Komiyama T. Recombinant Single-Chain Anti-idiotypic Antibody: An Effective Fungal β-1,3-Glucan Synthase Inhibitor. Biol Pharm Bull 2006, 29:1848-1853. 10.1248/bpb.29.1848, 16946497.
33. Orum H, Andersen PS, Oster A, Johansen LK, Riise E, Bjornvad M, Svendsen I, Engberg J. Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage. Nucleic Acids Res 1993, 21:4491-4498. 10.1093/nar/21.19.4491, 311180, 8233782.
34. Santala V, Saviranta P. Affinity-independent elution of antibody-displaying phages using cleavable DNA linker containing streptavidin beads. J Immunol Methods 2004, 284:159-163. 10.1016/j.jim.2003.10.013, 14736426.
35. Ward RL, Clark MA, Lees J, Hawkins NJ. Retrieval of human antibodies from phage-display libraries using enzymatic cleavage. J Immunol Methods 1996, 189:73-82. 10.1016/0022-1759(95)00231-6, 8576582.
36. Kasahara S, Inoue SB, Mio T, Yamada T, Nakajima T, Ichishima E, Furuichi Y, Yamada H. Involvement of cell wall beta-glucan in the action of HM-1 killer toxin. FEBS Lett 1994, 348:27-32. 10.1016/0014-5793(94)00575-3, 8026578.
37. Komiyama T, Ohta T, Urakami H, Shiratori Y, Takasuka T, Sato M, Watanabe T, Furuichi Y. Pore formation on proliferating yeast Saccharomyces cerevisiae cell buds by HM-1 killer toxin. J Biochem 1996, 119:731-736.
38. Komiyama T, Ohta T, Furuchi Y, Otha Y, Tsukada Y. Structure and activity of HYI killer toxin from Hansenula saturnus. Biol Pharm Bull 1995, 8:1057-1059.
39. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domain. Nature 1990, 348:552-554. 10.1038/348552a0, 2247164.
40. Kabat EA, Wu TT. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J Immunol 1991, 147:1709-1719.
41. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 10.1038/227680a0, 5432063.
42. Komiyama T, Shirai T, Ohta T, Urakami H, Furuichi Y, Ohta Y, Tsukada Y. Action properties of HYI killer toxin from Williopsis saturnus v ar. saturnus, and antibiotics, aculeacin A and papulacandin B. Biol Pharm Bull 1998, 21:1013-1019.
43. Gruen LC, Kortt AA, Nice E. Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology. Eur J Biochem 1993, 217:319-325. 10.1111/j.1432-1033.1993.tb18249.x, 8223570.
44. Kabat EA, Wu TT, Perry H, Gottesman K, Foeller C. Sequences of proteins of immunological interest. 1991, National Institutes of Health, Bethesda, Md, 5.